Glucagon-like peptide-1 receptor agonists are associated with decreased risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy

被引：0
|
作者：
Tauqeer, Zujaja [1 ]
Bracha, Peter [1 ,2 ]
Hua, Peiying [3 ]
Cui, Qi N. [1 ]
VanderBeek, Brian L. [1 ,4 ]
机构：
[1] Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA USA
[2] Gundersen Hlth Syst, Gundersen Eye Inst, La Crosse, WI USA
[3] Univ Penn, Perelman Sch Med, Ctr Preventat Ophthalmol & Biostat, Philadelphia, PA 19104 USA
[4] Univ Penn, Perelman Sch Med, Ctr Pharmacoepidemiol Res & Training, Philadelphia, PA 19104 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2021年 / 62卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Use of glucagon-like peptide-1 receptor agonist and risk of progression to vision threatening diabetic retinopathy
    VanderBeek, Brian L.
    Tauqeer, Zujaja
    Bracha, Peter
    Hua, Peiying
    Cui, Qi
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 384 - 384
  • [2] Glucagon-Like Peptide-1 Receptor Agonists are Not Associated with an Increased Risk of Progressing to Vision-Threatening Diabetic Retinopathy
    Tauqeer, Zujaja
    Bracha, Peter
    Hua, Peiying
    Yu, Yinxi
    Cui, Qi N.
    Vanderbeek, Brian L.
    OPHTHALMIC EPIDEMIOLOGY, 2024,
  • [3] Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy
    Li, Yafeng
    Yu, Yinxi
    VanderBeek, Brian L.
    EYE, 2020, 34 (05) : 934 - 941
  • [4] Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy
    Yafeng Li
    Yinxi Yu
    Brian L. VanderBeek
    Eye, 2020, 34 : 934 - 941
  • [5] Glucagon-like peptide-1 receptor agonists and the risk of incident diabetic retinopathy
    Douros, Antonios
    Filion, Kristian B.
    Yin, Hui
    Yu, Oriana H.
    Etminan, Mahyar
    Udell, Jacob A.
    Azoulay, Laurent
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 451 - 451
  • [6] The potential benefits of glucagon-like peptide-1 receptor agonists for diabetic retinopathy
    Pang, Baoying
    Zhou, Huanran
    Kuang, Hongyu
    PEPTIDES, 2018, 100 : 123 - 126
  • [7] Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy
    Douros, Antonios
    Filion, Kristian B.
    Yin, Hui
    Yu, Oriana Hoi
    Etminan, Mahyar
    Udell, Jacob A.
    Azoulay, Laurent
    DIABETES CARE, 2018, 41 (11) : 2330 - 2338
  • [8] The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Diabetic Retinopathy at a Tertiary Care Center
    Joo, Julia H.
    Sharma, Neha
    Shaia, Jacqueline
    Wu, Anna K.
    Skugor, Mario
    Singh, Rishi P.
    V. Rachitskaya, Aleksandra
    OPHTHALMOLOGY SCIENCE, 2024, 4 (06):
  • [9] Glucagon-like peptide-1 receptor agonists and diabetic retinopathy: nationwide cohort and Mendelian randomization studies
    Deqiang Zheng
    Ning Li
    Rui Hou
    Xiaoyu Zhang
    Lijuan Wu
    Jan Sundquist
    Kristina Sundquist
    Jianguang Ji
    BMC Medicine, 21
  • [10] Glucagon-like peptide-1 receptor agonists and diabetic retinopathy: nationwide cohort and Mendelian randomization studies
    Zheng, Deqiang
    Li, Ning
    Hou, Rui
    Zhang, Xiaoyu
    Wu, Lijuan
    Sundquist, Jan
    Sundquist, Kristina
    Ji, Jianguang
    BMC MEDICINE, 2023, 21 (01)
12345